Tag: semaglutide

Dec142024 by adminNo Comments

U.S. adult weight problems rate fell in 2023, as usage of GLP-1 medications increased

The U.S. weight problems rate decreased for the very first time in a years in 2015, accompanying the increase of GLP-1 weight-loss medications, a brand-new research study discovers. Information on nearly 17 million grownups across the country revealed the weight problems rate-- which has actually been increasing for several years-- fell from 46.2% of grownups in 2021 to 45.6% in 2023, Harvard University scientists report. Weight problems was specified as having a body m...

Nov222024 by adminNo Comments

‘A Watershed Moment’: GLP-1 Drug Succeeds in Late-Stage MASH Trial

Health and Mediacal

Meeting Coverage > > AASLD-- First favorable stage III research study for a GLP-1 agonist in persistent liver illness by Mike Bassett, Staff Writer, MedPage Today November 20, 2024 Semaglutide (Wegovy) enhanced liver fibrosis in clients with metabolic dysfunction-associated steatohepatitis (MASH) and resulted in higher rates of MASH resolution, an interim analysis of a stage III trial revealed. In part 1 of the so-called ESSENCE trial, treatment with the GLP-1 receptor agonist led to greater week-72 rates of steatohepatitis resolution without getting worse of liver fibrosis (63% vs 34% with placebo) and enhancement in liver fibrosis without in...